... Sa increased its stake in Bristol Myers Squibb Co (BMY) by 92.17% based on its latest 2017Q3 regulatory filing with …
Bristol-Myers Squibb Company (NYSE:BMY) stock was upgraded from Equal-Weight to Overweight by Morgan Stanley analyst David Risinger and he raised the price target from $63 to $78. “We have greater confidence that Bristol’s Opdivo …
Bristol-Myers Squibb Company (NYSE:BMY ... Further, and in addition to the $1 …